Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-08-14

Clinical Trial Update: Efficacy and Safety of Ascending Dosages of Moxidectin and Moxidectin-albendazole Against Trichuris Trichiura [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating rising doses of moxidectin alone and with albendazole for efficacy and safety against Trichuris trichiura infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Albendazole (ALBENDAZOLE)
  • Moxidectin (moxidectin)

Snippet

Sponsor: Swiss Tropical & Public Health Institute | Conditions: Trichuris Trichiura; Infection | Phase 2 | Status: COMPLETED